✦ LIBER ✦

Procalcitonin in patients with acute and chronic renal insufficiency

✍ Scribed by Gerald Steinbach; Edwin Bölke; Adolf Grünert; Klaus Orth; Martin Störck

Publisher: Springer Vienna
Year: 2004
Tongue: English
Weight: 95 KB
Volume: 116
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-004-0279-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute effects of acetylsalicylic acid in

Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency

✍ K. J. Berg 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 604 KB

Is Carotid Endarterectomy Justified in P

Is Carotid Endarterectomy Justified in Patients with Severe Chronic Renal Insufficiency?

✍ Edward E. Rigdon; Navid Monajjem; Robert S. Rhodes 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 58 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency—Preliminary evaluation

✍ D. Craig Brater; David R. Rudy; James R. Voelker; Paula K. Greene; Todd Gehr; Do 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 433 KB

Cimetidine does not influence cellular i

Cimetidine does not influence cellular immunity in patients with chronic renal insufficiency

✍ F. Giacchino; G. Segoloni; G. Giachino; A. Jeantet; M. Pellerey; A. Vercellone; 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Pharmacokinetics of sotalol after chroni

Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency

✍ G. Berglund; R. Descamps; J. A. Thomis 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 490 KB

Oral pharmacokinetics of pirenzepine in

Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis

✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1